Natural products to drugs: natural product-derived compounds in clinical trials

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107

Natural products as sources of new drugs over the last 25 years

Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517

Resveratrol improves health and survival of mice on a high-calorie diet

Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290

The price of innovation: new estimates of drug development costs

DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265

Therapeutic potential of resveratrol: the in vivo evidence

Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796

Natural products as sources of new drugs over the period 1981–2002

Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082

The evolving role of natural products in drug discovery

Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572

Drugs for bad bugs: confronting the challenges of antibacterial discovery

Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393

Topoisomerase I inhibitors: camptothecins and beyond

Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277

Curcumin as “Curecumin”: From kitchen to clinic

Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214

Polymer conjugates as anticancer nanomedicines

Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

Vermeulen, K., Van Bockstaele, D. R., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,773

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.

VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687

Molecular Mechanisms of Antibacterial Multidrug Resistance

Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647

Natural Products in Drug Discovery and Development

Cragg, G. M., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,585

Inhibition of Proteasome Activities and Subunit-Specific Amino-Terminal Threonine Modification by Lactacystin

Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R. W., Alvar, J., & Boelaert, M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1748 · Cited by 1,490

The role of natural product chemistry in drug discovery

Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381

The antibiotic resistome: the nexus of chemical and genetic diversity

Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365

The influence of natural products upon drug discovery (Antiquity to late 1999)

Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293

The mechanism of action of aspirin

Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196

Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran

Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.002 · Cited by 1,177

Echinocandin antifungal drugs

Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090

Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora

Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057

Arming antibodies: prospects and challenges for immunoconjugates

Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052

Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment

Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036

Artemisinins target the SERCA of Plasmodium falciparum

Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

ENDO, A., KURODA, M., & TSUJITA, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

SEHGAL, S. N., BAKER, H., & VÉZINA, C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.727 · Cited by 947

The Process of Structure-Based Drug Design

Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 939

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. F., Rejniak, S. X., Gordon, K. A., DeBlanc, R., Toki, B. E., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0039 · Cited by 931

Phlorizin: a review

Ehrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases

Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914

Conus Venoms: A Rich Source of Novel Ion Channel-Targeted Peptides

TERLAU, H., & OLIVERA, B. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00020.2003 · Cited by 897

Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis

Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

Szallasi, A., Cortright, D. N., Blum, C. A., & Eid, S. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2280 · Cited by 879

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 875

Trends in antimicrobial drug development: Implications for the future

Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867

The discovery and development of HMG-CoA reductase inhibitors.

Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847

Chemistry and Biology of Roseophilin and the Prodigiosin Alkaloids: A Survey of the Last 2500 Years

Fürstner, A. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300582 · Cited by 827

Nutraceuticals: Facts and fiction

Espín, J. C., García-Conesa, M. T., & Tomás-Barberán, F. A. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.09.014 · Cited by 811

Therapeutic potential of venom peptides

Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798

Fragment-based lead discovery

Rees, D. C., Congreve, Murray, C. W., & Carr, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1467 · Cited by 798

Oral Miltefosine for Indian Visceral Leishmaniasis

Sundar, S., Jha, T. K., Thakur, C. P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., & Berman, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021556 · Cited by 779

Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials

Newman, D. J., & Cragg, G. M. (2004) · Journal of Natural Products · doi:10.1021/np040031y · Cited by 759

Where will new antibiotics come from?

Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755

Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

Casero, R. A., & Marton, L. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2243 · Cited by 751

Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications

de la Lastra, C. A., & Villegas, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351156 · Cited by 740

Drugs from the deep: Marine natural products as drug candidates

Haefner, B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02713-2 · Cited by 740

Resveratrol: A review of preclinical studies for human cancer prevention

ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731

Combinatorial Synthesis of Small Organic Molecules

Balkenhohl, F., von dem Bussche‐Hünnefeld, C., Lansky, A., & Zechel, C. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199622881 · Cited by 726

Glycosidase inhibitors: update and perspectives on practical use

Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 715

The future challenges facing the development of new antimicrobial drugs

Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704

The war against influenza: discovery and development of sialidase inhibitors

von Itzstein, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2400 · Cited by 702

Lipid II as a target for antibiotics

Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694

Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery

O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689

Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?

von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672

Drug discovery from natural sources

Chin, Y.-W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006) · The AAPS Journal · doi:10.1007/bf02854894 · Cited by 662

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709443104 · Cited by 659

Splicing factor SF3b as a target of the antitumor natural product pladienolide

Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657

Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS: A Randomized Controlled Trial

Staats, P. S., Yearwood, T., Charapata, S. G., Presley, R. W., Wallace, M. S., Byas-Smith, M., Fisher, R., Bryce, D. A., Mangieri, E. A., Luther, R. R., et al. (2004) · JAMA · doi:10.1001/jama.291.1.63 · Cited by 654

Isolation and structure of bryostatin 1

Pettit, G. R., Herald, C. L., Doubek, D. L., Herald, D. L., Arnold, E., & Clardy, J. (1982) · Journal of the American Chemical Society · doi:10.1021/ja00388a092 · Cited by 653

Comparative Review of the Carbapenems

Zhanel, G. G., Wiebe, R., Dilay, L., Thomson, K., Rubinstein, E., Hoban, D. J., Noreddin, A. M., & Karlowsky, J. A. (2007) · Drugs · doi:10.2165/00003495-200767070-00006 · Cited by 652

Pharmacological properties of the ubiquitous natural product betulin

Alakurtti, S., Mäkelä, T., Koskimies, S., & Yli-Kauhaluoma, J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.006 · Cited by 650

DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts

Giovanella, B. C., Stehlin, J. S., Wall, M. E., Wani, M. C., Nicholas, A. W., Liu, L. F., Silber, R., & Potmesil, M. (1989) · Science · doi:10.1126/science.2555920 · Cited by 650

The Lycopodium alkaloids

Ma, X., & Gang, D. R. (2004) · Natural Product Reports · doi:10.1039/b409720n · Cited by 649

Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer

Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

Smith, B. D., Levis, M., Beran, M., Giles, F., Kantarjian, H., Berg, K., Murphy, K. M., Dauses, T., Allebach, J., & Small, D. (2004) · Blood · doi:10.1182/blood-2003-11-3775 · Cited by 632

Epothilons A and B: Antifungal and Cytotoxic Compounds from Sorangium cellulosum (Myxobacteria). Production, Physico-chemical and Biological Properties.

GERTH, K., BEDORF, N., HÖFLE, G., IRSCHIK, H., & REICHENBACH, H. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.560 · Cited by 631

Identification of an antimalarial synthetic trioxolane drug development candidate

Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622

New antibiotics from bacterial natural products

Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610

Natural products in anticancer therapy

da Rocha, A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00063-7 · Cited by 604

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412

Weisberg, E., Boulton, C., Kelly, L. M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D. G., & Griffin, J. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00069-7 · Cited by 599

Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice

Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., & Fukushima, H. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a018 · Cited by 599

Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge

Heinrich, M., & Lee Teoh, H. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.02.012 · Cited by 584

Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing

Erickson, H. K., Park, P. U., Widdison, W. C., Kovtun, Y. V., Garrett, L. M., Hoffman, K., Lutz, R. J., Goldmacher, V. S., & Blättler, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4489 · Cited by 584

The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10

Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., & Bontems, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a070 · Cited by 583

Silybin and Silymarin - New and Emerging Applications in Medicine

Gazak, R., Walterova, D., & Kren, V. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941159 · Cited by 573

Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog

Spande, T. F., Garraffo, H. M., Edwards, M. W., Yeh, H. J. C., Pannell, L., & Daly, J. W. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00035a048 · Cited by 561

The Renaissance of Natural Products as Drug Candidates

Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559

SARS — beginning to understand a new virus

Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H.-D., & Rappuoli, R. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro775 · Cited by 557

HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

Kashman, Y., Gustafson, K. R., Fuller, R. W., Cardellina, J. H., McMahon, J. B., Currens, M. J., Buckheit, R. W., Hughes, S. H., Cragg, G. M., & Boyd, M. R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00093a004 · Cited by 552

Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite.

FUJITA, T., INOUE, K., YAMAMOTO, S., IKUMOTO, T., SASAKI, S., TOYAMA, R., CHIBA, K., HOSHINO, Y., & OKUMOTO, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.208 · Cited by 540

New aspects of natural products in drug discovery

Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531

Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 527

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

Ondetti, M. A., Williams, N. J., Sabo, E., Pluscec, J., Weaver, E. R., & Kocy, O. (1971) · Biochemistry · doi:10.1021/bi00798a004 · Cited by 521

Halichondrins-antitumor polyether macrolides from a marine sponge

Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519

Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective

Shu, Y.-Z. (1998) · Journal of Natural Products · doi:10.1021/np9800102 · Cited by 517

Epothilone A and B—Novel 16‐Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution

Höfle, G., Bedorf, N., Steinmetz, H., Schomburg, D., Gerth, K., & Reichenbach, H. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199615671 · Cited by 515

Recent progress in the development of coumarin derivatives as potent anti‐HIV agents

Yu, D., Suzuki, M., Xie, L., Morris‐Natschke, S. L., & Lee, K. (2003) · Medicinal Research Reviews · doi:10.1002/med.10034 · Cited by 515

Thienamycin, a new .BETA.-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

KAHAN, J. S., KAHAN, F. M., GOEGELMAN, R., CURRIE, S. A., JACKSON, M., STAPLEY, E. O., MILLER, T. W., MILLER, A. K., HENDLIN, D., MOCHALES, S., et al. (1979) · The Journal of Antibiotics · doi:10.7164/antibiotics.32.1 · Cited by 514

Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells.

OMURA, S., FUJIMOTO, T., OTOGURO, K., MATSUZAKI, K., MORIGUCHI, R., TANAKA, H., & SASAKI, Y. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.113 · Cited by 509

Why is big Pharma getting out of antibacterial drug discovery?

Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Sandor, V. A., Bakke, S., Robey, R. W., Kang, M. H., Blagosklonny, M. V., Bender, J., Brooks, R. A., Piekarz, R., Tucker, E. E., Figg, W. D., et al. (2002) · PubMed · Cited by 502

Tumor inhibitors. LXXIV. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii

Kupchan, S. M., Court, W. A., Dailey, R. G., Gilmore, C. J., & Bryan, R. F. (1972) · Journal of the American Chemical Society · doi:10.1021/ja00775a078 · Cited by 501

Key factors in the rising cost of new drug discovery and development

Dickson, M., & Gagnon, J. P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1382 · Cited by 498

Enzyme-Catalyzed Activation of Anticancer Prodrugs

Rooseboom, M., Commandeur, J. N. M., & Vermeulen, N. P. E. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.3 · Cited by 497

The biosynthesis and regulation of bacterial prodiginines

Williamson, N. R., Fineran, P. C., Leeper, F. J., & Salmond, G. P. C. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1531 · Cited by 492

Natural products to drugs: natural product derived compounds in clinical trials

Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491

FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.

UEDA, H., NAKAJIMA, H., HORI, Y., FUJITA, T., NISHIMURA, M., GOTO, T., & OKUHARA, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.301 · Cited by 489

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.

Towle, M. J., Salvato, K. A., Budrow, J., Wels, B. F., Kuznetsov, G., Aalfs, K. K., Welsh, S., Zheng, W., Seletsky, B. M., Palme, M. H., et al. (2001) · PubMed · Cited by 483

Plant-derived compounds in clinical trials

Saklani, A., & Kutty, S. K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.010 · Cited by 477

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells

Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476

The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity

Liu, J.-S., Zhu, Y.-L., Yu, C.-M., Zhou, Y.-Z., Han, Y.-Y., Wu, F.-W., & Qi, B.-F. (1986) · Canadian Journal of Chemistry · doi:10.1139/v86-137 · Cited by 473

Injectable Paromomycin for Visceral Leishmaniasis in India

Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471

Anti-AIDS Agents, 11. Betulinic Acid and Platanic Acid as Anti-HIV Principles from Syzigium claviflorum, and the Anti-HIV Activity of Structurally Related Triterpenoids

Fujioka, T., Kashiwada, Y., Kilkuskie, R. E., Cosentino, L. M., Ballas, L. M., Jiang, J. B., Janzen, W. P., Chen, I.-S., & Lee, K.-H. (1994) · Journal of Natural Products · doi:10.1021/np50104a008 · Cited by 470

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

Nielsen, L. L., Young, A. A., & Parkes, D. G. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.10.028 · Cited by 457

Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth

Schoner, W., & Scheiner-Bobis, G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00098.2007 · Cited by 456

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

Grosso, F., Jones, R. L., Demetri, G. D., Judson, I. R., Blay, J.-Y., Le Cesne, A., Sanfilippo, R., Casieri, P., Collini, P., Dileo, P., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70175-4 · Cited by 454

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Lee, F. Y., Borzilleri, R. M., Fairchild, C. R., Kim, S., Long, B. H., Raventós-Suárez, C., Vite, G. D., Rose, W. C., & Kramer, R. A. (2001) · PubMed · Cited by 453

Camptothecin: current perspectives

Thomas, C. J., Rahier, N. J., & Hecht, S. M. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.036 · Cited by 451

Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin

Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J. (1998) · Science · doi:10.1126/science.282.5392.1324 · Cited by 440

Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases

Billich, A., Bornancin, F., Dévay, P., Mechtcheriakova, D., Urtz, N., & Baumruker, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307687200 · Cited by 433

Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial

Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

Li, F., Goila-Gaur, R., Salzwedel, K., Kilgore, N. R., Reddick, M., Matallana, C., Castillo, A., Zoumplis, D., Martin, D. E., Orenstein, J. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234683100 · Cited by 426

Squalamine: an aminosterol antibiotic from the shark.

Moore, K. S., Wehrli, S., Roder, H., Rogers, M., Forrest, J. N., McCrimmon, D., & Zasloff, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1354 · Cited by 423

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.

Yu, K., Toral-Barza, L., Discafani, C., Zhang, W. G., Skotnicki, J., Frost, P., & Gibbons, J. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080249 · Cited by 420

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

Knapper, S., Burnett, A. K., Littlewood, T., Kell, W. J., Agrawal, S., Chopra, R., Clark, R., Levis, M. J., & Small, D. (2006) · Blood · doi:10.1182/blood-2006-04-015560 · Cited by 413

The value of natural products to future pharmaceutical discovery

Baker, D. D., Chu, M., Oza, U., & Rajgarhia, V. (2007) · Natural Product Reports · doi:10.1039/b602241n · Cited by 413

Antibiotics at the crossroads

Nathan, C. (2004) · Nature · doi:10.1038/431899a · Cited by 410

Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.

Kondapaka, S. B., Singh, S. S., Dasmahapatra, G. P., Sausville, E. A., & Roy, K. (2003) · PubMed · Cited by 407

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404

Total synthesis of halichondrin B and norhalichondrin B

Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400

Microsporidiosis: current status

Didier, E. S., & Weiss, L. M. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244055.46382.23 · Cited by 393

Natural products to drugs: daptomycin and related lipopeptide antibiotics

Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393

Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design

Davis, A. M., Teague, S. J., & Kleywegt, G. J. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200539 · Cited by 387

Small Molecule Natural Products in the Discovery of Therapeutic Agents: The Synthesis Connection

Wilson, R. M., & Danishefsky, S. J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0610053 · Cited by 387

Castanospermine, A 1,6,7,8-tetrahydroxyoctahydroindolizine alkaloid, from seeds of Castanospermum australe

Hohenschutz, L. D., Bell, E. A., Jewess, P. J., Leworthy, D. P., Pryce, R. J., Arnold, E., & Clardy, J. (1981) · Phytochemistry · doi:10.1016/0031-9422(81)85181-3 · Cited by 383

Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data

Bai, R. L., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., & Hamel, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98491-7 · Cited by 379

Isolation of Dolastatin 10 from the Marine Cyanobacterium Symploca Species VP642 and Total Stereochemistry and Biological Evaluation of Its Analogue Symplostatin 1

Luesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010049y · Cited by 378

Structure and synthesis of nojirimycin

Inouye, S., Tsuruoka, T., Ito, T., & Niida, T. (1968) · Tetrahedron · doi:10.1016/0040-4020(68)88115-3 · Cited by 377

Discodermolide: a new bioactive polyhydroxylated lactone from the marine sponge Discodermia dissoluta

Gunasekera, S. P., Gunasekera, M., Longley, R. E., & Schulte, G. K. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00303a029 · Cited by 375

Histone Deacetylase Inhibitors: From Bench to Clinic

Paris, M., Porcelloni, M., Binaschi, M., & Fattori, D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7011408 · Cited by 367

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

DiJoseph, J. F., Armellino, D. C., Boghaert, E. R., Khandke, K., Dougher, M. M., Sridharan, L., Kunz, A., Hamann, P. R., Gorovits, B., Udata, C., et al. (2004) · Blood · doi:10.1182/blood-2003-07-2466 · Cited by 361

Revisiting the ancient concept of botanical therapeutics

Schmidt, B. M., Ribnicky, D. M., Lipsky, P. E., & Raskin, I. (2007) · Nature Chemical Biology · doi:10.1038/nchembio0707-360 · Cited by 355

An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone

Bey, E. A., Bentle, M. S., Reinicke, K. E., Dong, Y., Yang, C.-R., Girard, L., Minna, J. D., Bornmann, W. G., Gao, J., & Boothman, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702176104 · Cited by 354

Camptothecin and Taxol: Historic Achievements in Natural Products Research

Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353

Immunosuppressive drugs: the first 50 years and a glance forward

Allison, A. C. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00186-7 · Cited by 350

(−)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells

Shimizu, M., Deguchi, A., Lim, J. T. E., Moriwaki, H., Kopelovich, L., & Weinstein, I. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2014 · Cited by 347

Epothilones: Mechanism of Action and Biologic Activity

Goodin, S., Kane, M. P., & Rubin, E. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.001 · Cited by 346

Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275

Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., & Sausville, E. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.22.1736 · Cited by 346

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 342

Recent Developments in the Maytansinoid Antitumor Agents

Cassady, J. M., Chan, K. K., Floss, H. G., & Leistner, E. (2004) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.52.1 · Cited by 342

Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells

Ye, K., Ke, Y., Keshava, N., Shanks, J., Kapp, J. A., Tekmal, R. R., Petros, J., & Joshi, H. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1601 · Cited by 341

A new antifungal antibiotic, trichostatin.

TSUJI, N., KOBAYASHI, M., NAGASHIMA, K., WAKISAKA, Y., & KOIZUMI, K. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1 · Cited by 341

Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.

WEIBEL, E. K., HADVARY, P., HOCHULI, E., KUPFER, E., & LENGSFELD, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1081 · Cited by 341

(S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1 H,13 H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2 H)-dione (LY333531) and Related Analogues: Isozyme Selective Inhibitors of Protein Kinase Cβ

Jirousek, M. R., Gillig, J. R., Gonzalez, C. M., Heath, W. F., McDonald, J. H., Neel, D. A., Rito, C. J., Singh, U., Stramm, L. E., Melikian-Badalian, A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950588y · Cited by 339

Natural products — The future scaffolds for novel antibiotics?

Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337

Combination of Trastuzumab and Tanespimycin (17-AAG, KOS-953) Is Safe and Active in Trastuzumab-Refractory HER-2–Overexpressing Breast Cancer: A Phase I Dose-Escalation Study

Modi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.7960 · Cited by 335

Mycophenolic Acid: A One Hundred Year Odyssey from Antibiotic to Immunosuppressant

Bentley, R. (2000) · Chemical Reviews · doi:10.1021/cr990097b · Cited by 330

Camptothecin, over four decades of surprising findings

Lorence, A., & Nessler, C. L. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.09.001 · Cited by 330

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

Chang, R., Lotti, V., Monaghan, R., Birnbaum, J., Stapley, E., Goetz, M., Albers-Schonberg, G., Patchett, A., Liesch, J., Hensens, O., et al. (1985) · Science · doi:10.1126/science.2994227 · Cited by 319

Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells

Boulay, A., Zumstein-Mecker, S., Stephan, C., Beuvink, I., Zilbermann, F., Haller, R., Tobler, S., Heusser, C., O’Reilly, T., Stolz, B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3554-2 · Cited by 318

Identification of the Putative Bryostatin Polyketide Synthase Gene Cluster from “Candidatus Endobugula sertula”, the Uncultivated Microbial Symbiont of the Marine Bryozoan Bugula neritina

Sudek, S., Lopanik, N. B., Waggoner, L. E., Hildebrand, M., Anderson, C., Liu, H., Patel, A., Sherman, D. H., & Haygood, M. G. (2007) · Journal of Natural Products · doi:10.1021/np060361d · Cited by 314

Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Plumb, J. A., Finn, P. W., Williams, R. J., Bandara, M. J., Romero, M., Watkins, C. J., Thangue, N. B. L., & Brown, R. E. (2003) · PubMed · Cited by 312

Crystal Structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in Complex with the 20S Proteasome Reveal Important Consequences of β-Lactone Ring Opening and a Mechanism for Irreversible Binding

Groll, M., Huber, R., & Potts, B. C. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058320b · Cited by 312

A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies

Giles, F., Fischer, T., Cortes, J., Garcia-Manero, G., Beck, J., Ravandi, F., Masson, E., Rae, P., Laird, G., Sharma, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0511 · Cited by 312

Multi-targeting by monotherapeutic antibacterials

Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311

Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase

Piña, I. C., Gautschi, J. T., Wang, G.-Y.-S., Sanders, M. L., Schmitz, F. J., France, D., Cornell-Kennon, S., Sambucetti, L. C., Remiszewski, S. W., Perez, L. B., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034248t · Cited by 311

Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer

Widdison, W. C., Wilhelm, S. D., Cavanagh, E. E., Whiteman, K. R., Leece, B. A., Kovtun, Y., Goldmacher, V. S., Xie, H., Steeves, R. M., Lutz, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060319f · Cited by 309

The Glycylcyclines: A Comparative Review with the Tetracyclines

Zhanel, G. G., Homenuik, K., Nichol, K., Noreddin, A., Vercaigne, L., Embil, J., Gin, A., Karlowsky, J. A., & Hoban, D. J. (2004) · Drugs · doi:10.2165/00003495-200464010-00005 · Cited by 306

Leishmaniasis: new approaches to disease control

Davies, C. R., Kaye, P., Croft, S. L., & Sundar, S. (2003) · BMJ · doi:10.1136/bmj.326.7385.377 · Cited by 303

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

Chan, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602162 · Cited by 301

Camptothecins: A Review of Their Chemotherapeutic Potential

Ulukan, H., & Swaan, P. W. (2002) · Drugs · doi:10.2165/00003495-200262140-00004 · Cited by 299

Tigecycline: A Critical Analysis

Stein, G. E., & Craig, W. A. (2006) · Clinical Infectious Diseases · doi:10.1086/505494 · Cited by 298

Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin

Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297

Betulinic Acid Inhibits Prostate Cancer Growth through Inhibition of Specificity Protein Transcription Factors

Chintharlapalli, S., Papineni, S., Ramaiah, S. K., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3735 · Cited by 297

Orlistat: its current status as an anti-obesity drug

Ballinger, A., & Peikin, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01422-x · Cited by 295

Challenges and new discoveries in the treatment of leishmaniasis

Singh, S., & Sivakumar, R. (2004) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-004-0348-9 · Cited by 293

Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist

Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292

Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease

The Parkinson Study Group PRECEPT Investigators (2007) · Neurology · doi:10.1212/01.wnl.0000277648.63931.c0 · Cited by 292

Norhalichondrin A: an antitumor polyether macrolide from a marine sponge

Uemura, D., Takahashi, K., Yamamoto, T., Katayama, C., Tanaka, J., Okumura, Y., & Hirata, Y. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00302a042 · Cited by 289

Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.

Bai, R. L., Pettit, G. R., & Hamel, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44880-0 · Cited by 286

Inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases

Saunier, B., Kilker, R. D., Tkacz, J. S., Quaroni, A., & Herscovics, A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45358-1 · Cited by 283

Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from Cyanosafracin B

Cuevas, C., Pérez, M., Martín, M. J., Chicharro, J. L., Fernández-Rivas, C., Flores, M., Francesch, A., Gallego, P., Zarzuelo, M., de la Calle, F., et al. (2000) · Organic Letters · doi:10.1021/ol0062502 · Cited by 282

Capsaicin (TRPV1 Agonist) Therapy for Pain Relief: Farewell or Revival?

Knotkova, H., Pappagallo, M., & Szallasi, A. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318158ed9e · Cited by 279

Capsaicin Binds to the Intracellular Domain of the Capsaicin-Activated Ion Channel

Jung, J., Hwang, S. W., Kwak, J., Lee, S.-Y., Kang, C.-J., Kim, W. B., Kim, D., & Oh, U. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00529.1999 · Cited by 279

Prospects for productivity

Booth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278

The way forward in HCV treatment — finding the right path

Manns, M. P., Foster, G. R., Rockstroh, J. K., Zeuzem, S., Zoulim, F., & Houghton, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2411 · Cited by 278

A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone

Kakizaki, I., Kojima, K., Takagaki, K., Endo, M., Kannagi, R., Ito, M., Maruo, Y., Sato, H., Yasuda, T., Mita, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405918200 · Cited by 277

Mechanism of action of oritavancin and related glycopeptide antibiotics

Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276

Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies

Mita, M. M., Mita, A. C., Chu, Q. S., Rowinsky, E. K., Fetterly, G. J., Goldston, M., Patnaik, A., Mathews, L., Ricart, A. D., Mays, T., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0345 · Cited by 273

Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents

Kashiwada, Y., Hashimoto, F., Cosentino, L. M., Chen, C.-H., Garrett, P. E., & Lee, K.-H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950922q · Cited by 272

Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells.

OMURA, S., MATSUZAKI, K., FUJIMOTO, T., KOSUGE, K., FURUYA, T., FUJITA, S., & NAKAGAWA, A. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.117 · Cited by 270

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Noel, G. J., Bush, K., Bagchi, P., Ianus, J., & Strauss, R. S. (2008) · Clinical Infectious Diseases · doi:10.1086/526527 · Cited by 270

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

Katsuno, K., Fujimori, Y., Takemura, Y., Hiratochi, M., Itoh, F., Komatsu, Y., Fujikura, H., & Isaji, M. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110296 · Cited by 267

Vascular disrupting agents in clinical development

Hinnen, P., & Eskens, F. A. L. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603694 · Cited by 263

Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2

Griffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15183 · Cited by 262

The exploration of macrocycles for drug discovery — an underexploited structural class

Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370

Photochemical Approaches to Complex Chemotypes: Applications in Natural Product Synthesis

Kärkäs, M. D., Porco, J. A., & Stephenson, C. R. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00760 · Cited by 1,017

The pharmaceutical industry and natural products: historical status and new trends

David, B., Wolfender, J.-L., & Dias, D. A. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-014-9367-z · Cited by 579

Flavonoids as prospective compounds for anti-cancer therapy

Ravishankar, D., Rajora, A. K., Greco, F., & Osborn, H. M. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.10.004 · Cited by 572

The Renaissance of Natural Products as Drug Candidates

Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559